Literature DB >> 24642177

Primary gut aspergillosis in a patient with acute myeloid leukaemia: the importance of early suspicion and definitive treatment.

Elizabeth Li1, Hayder Hussein, Adil Todiwala, Robert Kirby.   

Abstract

Aspergillus infection is a known complication in immunocompromised patients, particularly in those with impaired neutrophil function. The pathophysiology of respiratory tract infection and disseminated disease are well understood, and guidelines exist for early detection and treatment. The gut has been speculated to be the potential portal of entry for Aspergillus, though previous case series outline that this is often discovered late and results in high morbidity and mortality. Early clinical suspicion, with definitive surgical intervention and antifungal treatment with voriconazole, can significantly increase the chances of survival. In this article, the authors discuss a case of primary gut aspergillosis with secondary dissemination in a patient with acute myeloid leukaemia who developed serious sequelae.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24642177      PMCID: PMC3962853          DOI: 10.1136/bcr-2013-202316

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

2.  Clinical significance of extra-pulmonary involvement of invasive aspergillosis: a retrospective autopsy-based study of 107 patients.

Authors:  A Hori; M Kami; Y Kishi; U Machida; T Matsumura; T Kashima
Journal:  J Hosp Infect       Date:  2002-03       Impact factor: 3.926

3.  European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.

Authors:  J Maertens; O Marchetti; R Herbrecht; O A Cornely; U Flückiger; P Frêre; B Gachot; W J Heinz; C Lass-Flörl; P Ribaud; A Thiebaut; C Cordonnier
Journal:  Bone Marrow Transplant       Date:  2010-07-26       Impact factor: 5.483

4.  A retrospective series of gut aspergillosis in haematology patients.

Authors:  E Kazan; J Maertens; R Herbrecht; M Weisser; B Gachot; A Vekhoff; D Caillot; E Raffoux; T Fagot; O Reman; F Isnard; A Thiebaut; S Bretagne; C Cordonnier
Journal:  Clin Microbiol Infect       Date:  2011-04       Impact factor: 8.067

Review 5.  Primary invasive aspergillosis of the digestive tract: report of two cases and review of the literature.

Authors:  P Eggimann; J-C Chevrolet; M Starobinski; P Majno; M Totsch; B Chapuis; D Pittet
Journal:  Infection       Date:  2006-12       Impact factor: 3.553

  5 in total
  1 in total

1.  Gut Microbial Diversity Assessment of Indian Type-2-Diabetics Reveals Alterations in Eubacteria, Archaea, and Eukaryotes.

Authors:  Shrikant S Bhute; Mangesh V Suryavanshi; Suyog M Joshi; Chittaranjan S Yajnik; Yogesh S Shouche; Saroj S Ghaskadbi
Journal:  Front Microbiol       Date:  2017-02-14       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.